Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Olema Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- −1 vs. Q4 2022
- Shares held
- 33.4M
- +81.2K (+0.2%) vs. Q4 2022
- Total value
- $116.1M
- +$34.5M (+42.2%) vs. Q4 2022
- New holders
- 7
- 19 more added
- Sold out
- 8
- 26 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 28 | $97 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 246 | $854 | 0.00% | +4+1.7% | Added |
| Royal Bank of Canada | 358 | $1.00K | 0.00% | +276+336.6% | Added |
| Crewe Advisors LLC | 314 | $1.09K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 356 | $1.24K | 0.00% | −3,732−91.3% | Reduced |
| FMR LLC | 672 | $2.33K | 0.00% | −24−3.4% | Reduced |
| JPMorgan Chase & Co | 1,194 | $4.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,020 | $4.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 1,323 | $4.59K | 0.00% | +1,323 | New |
| Federated Hermes, Inc. | 1,709 | $5.93K | 0.00% | −1,865−52.2% | Reduced |
| Barclays PLC | 4,622 | $16.0K | 0.00% | +714+18.3% | Added |
| Citigroup Inc | 9,912 | $34.4K | 0.00% | +9,912 | New |
| Virtu Financial LLC | 10,015 | $35.0K | 0.00% | −3,500−25.9% | Reduced |
| PDT Partners, LLC | 10,573 | $36.7K | 0.00% | −12,841−54.8% | Reduced |
| HSBC Holdings PLC | 10,150 | $37.1K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,200 | $42.3K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 12,450 | $43.2K | 0.00% | −9,790−44.0% | Reduced |
| Tudor Investment Corp Et Al | 12,745 | $44.0K | 0.00% | −7,131−35.9% | Reduced |
| Cubist Systematic Strategies, LLC | 15,161 | $52.6K | 0.00% | +1,041+7.4% | Added |
| Prelude Capital Management, LLC | 16,225 | $56.3K | 0.00% | −3,726−18.7% | Reduced |
| Charles Schwab Investment Management Inc | 18,580 | $64.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,644 | $68.0K | 0.00% | +19,644 | New |
| Squarepoint Ops LLC | 23,943 | $83.1K | 0.00% | +23,943 | New |
| Conway Capital Management, Inc. | 26,500 | $92.0K | 0.08% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 29,150 | $101.0K | 0.00% | +19,358+197.7% | Added |
| Bank of America Corp | 29,393 | $102.0K | 0.00% | +1,042+3.7% | Added |
| Marshall Wace, LLP | 35,700 | $123.9K | 0.00% | −90,949−71.8% | Reduced |
| Man Group plc | – | $124.3K | 0.00% | – | New |
| Goldman Sachs Group Inc | 40,895 | $141.9K | 0.00% | +8,902+27.8% | Added |
| Cornercap Investment Counsel Inc | 51,152 | $177.5K | 0.03% | 00.0% | Unchanged |
| Jane Street Group, LLC | 55,370 | $192.1K | 0.00% | +43,964+385.4% | Added |
| Price T Rowe Associates Inc | 58,300 | $203.0K | 0.00% | −10,200−14.9% | Reduced |
| Northern Trust Corp | 72,992 | $253.3K | 0.00% | +5,374+7.9% | Added |
| Millennium Management LLC | 75,224 | $261.0K | 0.00% | −660,729−89.8% | Reduced |
| Susquehanna International Group, LLP | 88,016 | $305.4K | 0.00% | +88,016 | New |
| Morgan Stanley | 113,890 | $395.2K | 0.00% | −89,032−43.9% | Reduced |
| Bridgeway Capital Management, LLC | 115,687 | $401.4K | 0.01% | −22,000−16.0% | Reduced |
| State Street Corp | 121,181 | $420.5K | 0.00% | +12,100+11.1% | Added |
| Two Sigma Investments, LP | 161,433 | $560.2K | 0.00% | −22,839−12.4% | Reduced |
| Walleye Capital LLC | 182,337 | $632.7K | 0.01% | +151,036+482.5% | Added |
| Two Sigma Advisers, LP | 205,900 | $714.5K | 0.00% | −20,500−9.1% | Reduced |
| Dimensional Fund Advisors LP | 213,312 | $740.2K | 0.00% | +46,379+27.8% | Added |
| Monaco Asset Management SAM | 221,905 | $770.0K | 0.35% | −129,612−36.9% | Reduced |
| Gsa Capital Partners LLP | 230,632 | $800.0K | 0.08% | −1,001−0.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 230,568 | $800.1K | 0.00% | +178,740+344.9% | Added |
| Deutsche Bank AG | 254,718 | $883.9K | 0.00% | −201,948−44.2% | Reduced |
| Renaissance Technologies LLC | 257,200 | $892.0K | 0.00% | −9,000−3.4% | Reduced |
| Vontobel Holding Ltd. | 337,917 | $1.17M | 0.01% | −188,896−35.9% | Reduced |
| Geode Capital Management, LLC | 349,946 | $1.21M | 0.00% | +13,047+3.9% | Added |
| Newtyn Management, LLC | 375,000 | $1.30M | 0.26% | +15,000+4.2% | Added |
| Adage Capital Partners GP, L.L.C. | 420,000 | $1.46M | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 447,083 | $1.55M | 0.09% | −68,494−13.3% | Reduced |
| Laurion Capital Management LP | 513,972 | $1.78M | 0.08% | +18,672+3.8% | Added |
| Acadian Asset Management LLC | 575,900 | $2.00M | 0.01% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 995,909 | $3.46M | 0.66% | −445,896−30.9% | Reduced |
| BlackRock Inc. | 996,177 | $3.46M | 0.00% | −47,018−4.5% | Reduced |
| Citadel Advisors LLC | 1,230,516 | $4.27M | 0.00% | +5,366+0.4% | Added |
| Vanguard Group Inc | 1,507,767 | $5.23M | 0.00% | +32,417+2.2% | Added |
| Vivo Capital, LLC | 1,689,515 | $5.86M | 0.44% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 2,011,853 | $6.98M | 0.90% | −13,381−0.7% | Reduced |
| Janus Henderson Group PLC | 2,085,179 | $7.28M | 0.00% | −972,127−31.8% | Reduced |
| Paradigm Biocapital Advisors LP | 2,382,377 | $8.27M | 0.78% | +2,382,377 | New |
| Cormorant Asset Management, LP | 3,082,000 | $10.7M | 0.70% | +1,000,000+48.0% | Added |
| Logos Global Management LP | 3,743,875 | $13.0M | 1.86% | 00.0% | Unchanged |
| BVF Inc | 7,611,503 | $26.4M | 0.97% | 00.0% | Unchanged |
| EP Wealth Advisors, LLC | 4,508 | – | – | −41,740−90.3% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −318,926−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −260,500−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −133,157−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −129,631−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −38,906−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −16,322−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −11,991−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |